Jeuveau works much like other neuromodulators by temporarily relaxing targeted facial muscles. By reducing repetitive movements, it smooths existing lines while helping to prevent new ones from becoming more pronounced. Below are some distinct features of Jeuveau:

 

Modern Manufacturing: Often called "NewTox", it is a more modern neuromodulator, specifically only for aesthetic use. It uses Hi-Pure technology which is a purification process that includes extra filtration steps to yield a refined formulation. It is also produced in a state of the art facility with optimal sterility standards. All in all, its manufacturing incorporates more recent biotech advances, as compared to older produts with legacy manufacturing methods. 

​

Quicker Onset: Results typically appear within 2-5 days and last about 3–4 months. 52% of Millennials saw visible changes in just 2 days, this is especially useful when planning around events. 

​

Clinical precision: Jeuveau has less diffusion at the injection site, which may aid in reducing its unintended spread to nearby muscles (less risk of droop or heaviness). Because of its limited spread, it is an ideal option when needing targeted, controlled, treatment, especially in smaller muscles or more delicate zones. 

​

Key Relevant Research: Studies show a high responder rate at day 30 as compared to Botox, and far better than placebo. Multiple studies report that Jeuveau works more quickly, often faster than Botox. Recent publications for high dose Jeuveau reported effects lasting up to 6 months with safety. Compared to older toxins, Long term studies showed Jeuveau to be well trolerated, with low incidence of antibodies (reduced risk of building resistance) and no major safety issues. 

​

​